MAPT and Alzheimer disease: Similar findings were obtained in a study on a transgenic mouse model of AD (PS19), where inoculating synthetic tau fibrils into the hippocampus stimulated changes in endogenous tau protein and their further spread to anatomically connected areas of the brain [43].